Analysts See Ritter Pharmaceuticals Inc. (RTTR) Rising 96.0%

    Publicly-traded company Ritter Pharmaceuticals Inc. (NASDAQ:RTTR) had a closing price of $0.28 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $7.00, this means that the stock is underpriced by 96.0%. In the past 52 weeks the company’s stock price has moved within the range of $0.23 to $1.35.

    This particular stock’s 5-day moving average is 0.26, its 20-day moving average is 0.28 and its 100-day moving average is 0.73. Ritter Pharmaceuticals Inc. (RTTR) currently has 9.29M shares outstanding, which means that its market capitalization is $2.60M.

    The Details: Ritter Pharmaceuticals Inc. (RTTR) Financial Health

    Return on Assets is a number, expressed as a percentage that tells us how well a publicly-traded company is using its current assets to generate revenue. The higher the percentage, the better a company is using its assets to turn a profit. At the moment, Ritter Pharmaceuticals Inc. Return on Assets is -201.80%.

    What Does Wall Street Say about Company?

    When choosing stocks, many investors search for what Wall Street professionals think about the company first – like what the average rating is. At the moment, the average analyst rating for RTTR is Hold. Out of 1 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 1 rated it hold, and 0 rated it a Buy.

    Understanding Profitability at Ritter Pharmaceuticals Inc. (RTTR)

    Wall Street analysts, on average, are forecasting the company’s EPS to be -0.23, compared to -0.86 reported in the same quarter last year.